title: New drug update: 2012.
abstract: Five new drugs that are used for medical problems often experienced by the elderly have been selected for consideration in this review. The uses and most important properties of these agents are considered, and a rating for each new drug is determined. The rating is based on a comparison of the new drug with related drugs already marketed. Advantages, disadvantages, and other important information regarding the new drug are identified and used as the basis for determining the rating.
authors.affiliation: Philadelphia College of Pharmacy, University of the Sciences, Philadelphia, Pennsylvania, USA.
authors.forename: Daniel A
authors.initials: DA
authors.lastname: Hussar
mesh_terms: D000083:Acetanilides / Q000009:adverse effects / Q000494:pharmacology / Q000627:therapeutic use; D000368:Aged; D001993:Bronchodilator Agents / Q000009:adverse effects / Q000494:pharmacology / Q000627:therapeutic use; D003248:Constipation / Q000188:drug therapy; D017277:Drug Approval; D005901:Glaucoma / Q000188:drug therapy; D006801:Humans; D010455:Peptides / Q000009:adverse effects / Q000494:pharmacology / Q000627:therapeutic use; D011460:Prostaglandins F / Q000009:adverse effects / Q000494:pharmacology / Q000627:therapeutic use; D013844:Thiazoles / Q000009:adverse effects / Q000494:pharmacology / Q000627:therapeutic use; D014481:United States; D053201:Urinary Bladder, Overactive / Q000188:drug therapy
chemical_list: D000083:Acetanilides; D001993:Bronchodilator Agents; D010455:Peptides; D011460:Prostaglandins F; D013844:Thiazoles; C485333:tafluprost; C520025:mirabegron; C523483:linaclotide